We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.52B
AUM Growth
+$1.2B
Cap. Flow
+$726M
Cap. Flow %
9.65%
Top 10 Hldgs %
19.11%
Holding
866
New
79
Increased
318
Reduced
279
Closed
56

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$75M
2
BIIB icon
Biogen
BIIB
+$70.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$60.1M
4
MRK icon
Merck
MRK
+$54.6M
5
GILD icon
Gilead Sciences
GILD
+$33.1M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$19.1M
2
IRBT
iRobot
IRBT
+$15.5M
3
DGX icon
Quest Diagnostics
DGX
+$15.4M
4
CL icon
Colgate-Palmolive
CL
+$14.8M
5
PM icon
Philip Morris
PM
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33.26%
2 Technology 16.05%
3 Financials 11.26%
4 Consumer Discretionary 7.98%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
26
AbbVie
ABBV
$458B
$49.2M 0.65%
520,401
+8,017
+2% +$760K
T icon
27
AT&T
T
$165B
$48.1M 0.64%
1,897,108
+153,331
+9% +$3.76M
A icon
28
Agilent Technologies
A
$39.1B
$47M 0.62%
666,102
+109,019
+20% +$7.21M
DHR icon
29
Danaher
DHR
$135B
$46.4M 0.62%
482,016
+329,026
+215% +$30M
VZ icon
30
Verizon
VZ
$194B
$45.9M 0.61%
859,315
+11,575
+1% +$613K
BRK.B icon
31
Berkshire Hathaway Class B
BRK.B
$1.07T
$44.6M 0.59%
208,374
+5,580
+3% +$1.14M
ABT icon
32
Abbott
ABT
$180B
$42.9M 0.57%
584,618
-42,892
-7% -$2.82M
AXP icon
33
American Express
AXP
$223B
$40.3M 0.54%
378,364
+6,401
+2% +$666K
BMRN icon
34
BioMarin Pharmaceuticals
BMRN
$11.5B
$39.2M 0.52%
403,993
+138,700
+52% +$13.8M
UNH icon
35
UnitedHealth
UNH
$382B
$38.7M 0.51%
145,586
-21,897
-13% -$5.7M
EC icon
36
Ecopetrol
EC
$32.9B
$38.5M 0.51%
1,429,000
+703,000
+97% +$15.5M
CRM icon
37
Salesforce
CRM
$134B
$38.3M 0.51%
240,558
-30,816
-11% -$4.57M
GOOG icon
38
Alphabet (Google) Class C
GOOG
$3.9T
$38M 0.5%
636,140
-50,740
-7% -$3.04M
C icon
39
Citigroup
C
$222B
$37.1M 0.49%
516,655
+109,966
+27% +$7.77M
IMMU
40
DELISTED
Immunomedics Inc
IMMU
$36.8M 0.49%
1,765,500
+1,027,500
+139% +$24.3M
PTC icon
41
PTC
PTC
$13.7B
$36.2M 0.48%
340,447
+14,666
+5% +$1.43M
ROK icon
42
Rockwell Automation
ROK
$51.4B
$35.4M 0.47%
188,859
+38,359
+25% +$6.87M
CI icon
43
Cigna
CI
$76.6B
$34.2M 0.46%
164,399
+157
+0.1% +$29.1K
CMCSA icon
44
Comcast
CMCSA
$79.1B
$33.6M 0.45%
950,151
-30,117
-3% -$1.07M
ISRG icon
45
Intuitive Surgical
ISRG
$121B
$33M 0.44%
172,401
+9,522
+6% +$1.69M
COP icon
46
ConocoPhillips
COP
$147B
$32.4M 0.43%
417,996
+57,898
+16% +$4.18M
AMAT icon
47
Applied Materials
AMAT
$426B
$32.2M 0.43%
833,155
+30,718
+4% +$1.36M
NVDA icon
48
NVIDIA
NVDA
$5.01T
$32.1M 0.43%
4,572,200
+449,200
+11% +$2.92M
IBM icon
49
IBM
IBM
$202B
$30.6M 0.41%
211,854
+75,540
+55% +$10.6M
ADSK icon
50
Autodesk
ADSK
$44.3B
$30.1M 0.4%
193,044
+40,865
+27% +$5.77M

Similar funds

Candriam SCA's Q3 2018 Portfolio in Review

As of Q3 2018, Candriam SCA held 866 positions worth $7.52B, up 19% from $6.32B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA deployed $726M of net new capital in Q3 2018, opening 79 new positions and adding to 318 existing holdings. Its largest new stake was Varonis Systems: 541,092 shares worth $13.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $19.1M trimmed.

  • Candriam SCA's largest Q3 2018 buy was Varonis Systems: 541,092 shares worth $13.2M.
  • Candriam SCA added most to Amgen in Q3 2018, an estimated $75M increase.
  • Candriam SCA's biggest Q3 2018 reduction was Advanced Micro Devices, cutting an estimated $19.1M.
  • Candriam SCA fully exited iRobot in Q3 2018, selling an estimated $15.5M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.52B portfolio in Q3 2018.
  • Candriam SCA opened 79 new positions and closed 56 in Q3 2018.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $7.52B.

Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.